CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Commercial Officer acquired 303,300 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 223,950 shares (grant or award)
- 4 Grant or award SVP, Chief Operating Officer acquired 149,300 shares (grant or award)
- 4 Grant or award SVP, CFO and Treasurer acquired 149,300 shares (grant or award)
- 4 Grant or award SVP, Chief Legal Officer acquired 149,300 shares (grant or award)
- 4 Open-market sale CEO and President sold 46,489 shares at $1.68 ($78,102)
- 4 Open-market sale SVP, Chief Medical Officer sold 24,311 shares at $1.68 ($40,842)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Other events
- 10-Q Report Quarterly Report
Page 9 of 45 · 886 filings